Gilead Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Once-Daily Descovy Biotech Investing
Celgene and Acceleration Pharma Announce Submission of Luspatercept Biologics License Application to FDA Biotech Investing
Endo Begins Shipment of Authorized Generic Version of PROVENTIL HFA Inhalation Aerosol in the US Pharmaceutical Investing
SELLAS Life Sciences Group and Cancer Center to Study Galinpepimut-S in Combination with Nivolumab in Patients with Malignant Pleural Mesothelioma Pharmaceutical Investing
BELLUS Health Receives Clearance of U.S. IND for BLU-5937 Phase 2 Study in Chronic Cough Patients Biotech Investing
NewLink Genetics Presents Phase 2 Results for NLG207 in Ovarian Cancer at AACR 2019 Genetics Investing
Hemispherx Announces First Participant Received Initial Dosing in Breast Cancer Clinical Trial Pharmaceutical Investing
